UNSPSC 51241549: Polyvinyl alcohol/povidone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP500. This VA Drug Class (OP500) classifies this compound as belonging to the group EYE WASHES/LUBRICANTS.

UNSPSC 51241549 Polyvinyl alcohol/povidone is a Commodity code covering pharmaceutical and over-the-counter chemical products that state and local governments procure through cooperative purchasing vehicles and direct supply agreements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary recent activity under this code. State and local health agencies, correctional facilities, and other government health-service entities purchase these products as components of pharmaceutical manufacturing and formulation, often sourcing through authorized wholesaler networks rather than direct manufacturer engagement. The work involves manufacturers or distributors meeting Good Manufacturing Practice (cGMP) and Drug Supply Chain Security Act (DSCSA) compliance, maintaining relationships with approved wholesalers, and supplying products with specified National Drug Codes, SKUs, and packaging configurations to support government healthcare operations.

MMCAP's January 2026 RFP for Generic Multi-Source Pharmaceuticals and Over-the-Counter Products (Solicitation S1070000015802, due March 26, 2026) is the primary representative opportunity on record. Participating states include Minnesota and Oregon, with products to be distributed across multiple state and local government facilities effective July 1, 2026. Vendors must maintain contractual relationships with at least two of three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and carry comprehensive insurance including $5,000,000 commercial general liability. Evaluation emphasizes price competitiveness (75 percent weight), with administrative requirements including EDI capability, compliance with data format standards, and acceptance of a 3 percent administrative fee. The contract term runs two years for new respondents with optional extensions, or through June 30, 2028 for incumbent amendments.